Therapeutic nanoparticles containing argonaute for microRNA delivery and compositions and methods using same

The present invention relates to oligonucleotide carriers for oligonucleotide delivery to a subject to provide gene therapy. More particularly, the present invention relates to therapeutic nanoparticles for microRNA (miRNA) delivery to a subject. More particularly, the present invention relates to t...

Full description

Saved in:
Bibliographic Details
Main Authors Akkoc, Yunus, Gozuacik, Devrim, Kosar, Ali, Unal, Ozlem, Kocak, Muhammed, Acar, Havva Yagci, Zuvin, Merve
Format Patent
LanguageEnglish
Published 03.06.2025
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The present invention relates to oligonucleotide carriers for oligonucleotide delivery to a subject to provide gene therapy. More particularly, the present invention relates to therapeutic nanoparticles for microRNA (miRNA) delivery to a subject. More particularly, the present invention relates to therapeutic nanoparticles wherein miRNA is bindable to biocompatible nanoparticles using natural gene carrier Argonaute (AGO) protein or a variant thereof. Optionally, therapeutic nanoparticles of the present invention additionally contain targeting moieties for targeting therapeutic nanoparticles to cancer cells and/or chemotherapeutic agents. Optionally, biocompatible nanoparticles are trackable nanoparticles, such as superparamagnetic iron oxide nanoparticles (SPION), to provide multifunctional theranostics.
Bibliography:Application Number: US201816978067